DR. MEAGAN ANNE JACOBY MD NPI 1447371786

NPI Information

  • NPI: 1447371786
  • Provider Name: DR. MEAGAN ANNE JACOBY, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4500 FOREST PARK AVE
    DIV IM BONE MARROW TRANSPLANT, 5TH, 6TH, 8TH FL
    SAINT LOUIS, MO
    ZIP 63108
  • Phone: (314) 454-8304

Map and Directions

Get Directions

NPI Details

DR. Meagan Anne Jacoby, MD is a medical oncology internal medicine in Saint Louis, MO with 21 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Meagan Anne Jacoby, MD NPI is 1447371786. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

4500 FOREST PARK AVE
DIV IM BONE MARROW TRANSPLANT, 5TH, 6TH, 8TH FL
SAINT LOUIS, MO
ZIP 63108-114
Phone: (314) 454-8304
Fax: (314) 454-5902

The NPI 1447371786 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Unclassified drugs (HCPCS:J3490)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Transfusion of blood or blood products (HCPCS:36430)

The enumeration date for this NPI number is 4/3/2007 and was last updated on 4/17/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology2011009915MISSOURIYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1205647704MEDICAIDMISSOURI

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.